SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001615219-22-000126
Filing Date
2022-08-05
Accepted
2022-08-05 16:30:17
Documents
9

Document Format Files

Seq Description Document Type Size
1 S-3 salarius-formsx32022shelfr.htm S-3 440478
2 EX-FILING FEES exhibit107-filingfees.htm EX-FILING FEES 31769
3 EX-4.7 exhibit47-formofindenture.htm EX-4.7 536304
4 EX-5.1 exhibit51-opinionbaseprosp.htm EX-5.1 25986
5 EX-5.2 exhibit52-opinionatmprospe.htm EX-5.2 13849
6 EX-23.1 eyconsent-draft.htm EX-23.1 2969
7 image_0.jpg GRAPHIC 28105
8 image_0a.jpg GRAPHIC 14569
9 image_0b.jpg GRAPHIC 28105
  Complete submission text file 0001615219-22-000126.txt   1149956
Mailing Address 2450 HOLCOMBE BLVD SUITE J-608 HOUSTON TX 77021
Business Address 2450 HOLCOMBE BLVD SUITE J-608 HOUSTON TX 77021 346-772-0346
Salarius Pharmaceuticals, Inc. (Filer) CIK: 0001615219 (see all company filings)

IRS No.: 465087339 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-266589 | Film No.: 221141257
SIC: 2834 Pharmaceutical Preparations